Dr. Alan P. Baltz, MD

Dr. Baltz practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Baltz's NPI, 1407352040, was assigned on April 3, 2018. Dr. Baltz graduated from University of Arkansas College of Medicine in 2018. Dr. Baltz holds Arkansas license E-18335.

Dr. Baltz's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Baltz's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Baltz to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baltz practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Baltz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Baltz is licensed in Arkansas.

CMS data shows 28 Medicare services from Dr. Baltz across 2 procedure codes in 2024, all of them office visits, for 31 Medicare patients. Medicare paid $1,778 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Baltz in 2024. The largest group is under 65, with 12 patients. 75% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baltz's median patient age at 60, with 56% women.

In 2024, Dr. Baltz wrote 25 Medicare Part D claims. 56% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $85 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Baltz for performance year 2024, reported through an alternative payment model (APM). Dr. Baltz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Baltz, published from 2019 to 2024. 2023 was the busiest year, with 2. Dr. Baltz's most frequent co-authors are Sajjad Akbar Bhatti, MBBS, Tyler Fugere, MD and Akash Mukherjee, MD.

CMS Open Payments shows 2 general payments to Dr. Baltz from 2 drug and device companies in 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $17.

Dr. Baltz graduated from University of Arkansas College of Medicine in 2018.